Skip navigation

Achieve Excellence in Financial Planning, Forecasting, Gross-to-Net, Corporate Controllership and External Reporting

June 16-17, 2020
  • San Francisco, CA

For CFOs, Corporate Controllers and Finance/Accounting teams, this event convenes executives from life sciences organizations to discuss strategies for effective financial planning, reporting, forecasting, governance and technology transformation. Gain insight into the unique challenges faced by other small and mid-sized biotech and pharmaceutical companies, including making the transition from private to public, entering into collaborations, cultivating talent, recognizing revenue, forecasting gross-to-net accruals, commercializing products and more!

Attendance Benefits Include:

  • CPE and CLE credits centered-on highly focused content, specific for life science companies
  • Up to the minute insight on the implications of new accounting rules, compliance issues and tax changes
  • Opportunity for peer-to-peer benchmarking on issues such as organizational structure, staffing, frequency of forecast adjustments, data management approaches, technology/systems
  • Customizable learning with choice of two workshops and two tracks of sessions

Hot Topics:

  • Product launch planning from a finance perspective
  • Gross-to-net accruals, forecasting and management
  • Building high-functioning teams and cultivating talent within finance
  • ERP systems – Case studies of implementations and systems strategies to scale for growth
  • IPO readiness and strategies for transitioning to the public markets
  • Corporate tax reform and assessment of impact to life science companies
  • Accounting for collaborative arrangements and R&D deals
  • Revenue recognition 2.0 – Lessons gleaned to date from implementation of changes
  • Lease accounting implementation
  • Product pricing and reimbursement issues
  • Outcomes-based contracting and implications from an accounting standpoint
  • Managing third parties and CRO oversight

Financial Strategies and Accounting for Bioscience Companies

Achieve Excellence in Financial Planning, Forecasting, Gross-to-Net, Corporate Controllership and External Reporting

For CFOs, Corporate Controllers and Finance/Accounting teams, this event convenes executives from life sciences organizations to discuss strategies for effective financial planning, reporting, forecasting, governance and technology transformation. Gain insight into the unique challenges faced by other small and mid-sized biotech and pharmaceutical companies, including making the transition from private to public, entering into collaborations, cultivating talent, recognizing revenue, forecasting gross-to-net accruals, commercializing products and more!

Attendance Benefits Include:

  • CPE and CLE credits centered-on highly focused content, specific for life science companies
  • Up to the minute insight on the implications of new accounting rules, compliance issues and tax changes
  • Opportunity for peer-to-peer benchmarking on issues such as organizational structure, staffing, frequency of forecast adjustments, data management approaches, technology/systems
  • Customizable learning with choice of two workshops and two tracks of sessions

Hot Topics:

  • Product launch planning from a finance perspective
  • Gross-to-net accruals, forecasting and management
  • Building high-functioning teams and cultivating talent within finance
  • ERP systems – Case studies of implementations and systems strategies to scale for growth
  • IPO readiness and strategies for transitioning to the public markets
  • Corporate tax reform and assessment of impact to life science companies
  • Accounting for collaborative arrangements and R&D deals
  • Revenue recognition 2.0 – Lessons gleaned to date from implementation of changes
  • Lease accounting implementation
  • Product pricing and reimbursement issues
  • Outcomes-based contracting and implications from an accounting standpoint
  • Managing third parties and CRO oversight